The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F 2 α -III, an Index of Oxidant Stress
Abstract
Oxidative stress has been suggested as a potential mechanism in the pathogenesis of chronic obstructive pulmonary disease (COPD). It has been difficult to address this hypothesis because of the limitations of conventional indices of lipid peroxidation in vivo. F2-isoprostanes (iPs) are prostaglandin isomers formed by free radical dependent peroxidation of arachidonic acid. Urinary iPF2alpha-III is a relatively abundant iPs produced in humans. In the present study, we investigated whether COPD is associated with enhanced oxidative stress by measuring urinary levels of this compound. Urinary excretion of iPF2alpha-III was determined in 38 patients with COPD and 30 sex- and age-matched healthy control subjects. Levels of iPF2alpha-III were significantly higher in patients with COPD (median, 84 pmol/ mmol creatinine; range, 38 to 321) than in healthy controls (median, 35.5 pmol/mmol creatinine; range, 15 to 65) (p < 0.0001). This elevation was independent of age, sex, smoking history, or duration of the disease. An inverse relationship was observed with the level of PaO2 (r = -0.38, p = 0. 019). Aspirin treatment failed to decrease urinary levels of iPF2alpha-III (102 +/- 8 versus 99.2 +/- 7.3 pmol/ mmol creatinine), whereas 11-dehydro TxB2 was significantly reduced (695 +/- 74 versus 95 +/- 10 pmol/mmol creatinine) (p < 0.0001). Elevated levels of iPF2alpha-III (median, 125 pmol/mmol creatinine; range, 110 to 170) in five patients with COPD declined (median, 90 pmol/mmol creatinine; range, 70 to 110) (p < 0.001) as an acute exacerbation in their clinical condition resolved. Increased urinary iPF2alpha-III is consistent with the hypothesis that oxidative stress occurs in COPD. This provides a basis for dose finding and evaluation of antioxidant therapy in the treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Siafakas, N., Vermeire, P., Pride, N., Paoletti, P., Gibson, J., Howard, P., Yernault, J., Decramer, M., Higenbottam, T., Postma, D., et al. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081398 · Cited by 1,592
Free-radical mechanisms in tissue injury
Slater, T. F. (1984) · Biochemical Journal · doi:10.1042/bj2220001 · Cited by 1,538
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
The measurement and mechanism of lipid peroxidation in biological systems
Gutteridge, J. M. C., & Halliwell, B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,283
Christman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Oxidative Stress in Chronic Obstructive Pulmonary Disease
REPINE, J. E., BAST, A., LANKHORST, I., & The Oxidative Stress Study Group (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9611013 · Cited by 843
Systemic oxidative stress in asthma, COPD, and smokers
Rahman, I., Morrison, D., Donaldson, K., & MacNee, W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887607 · Cited by 774 · cited 2×
“ROS have long been implicated in adult respiratory distress syndrome (ARDS) (3), in emphysema, and in chronic obstructive pulmonary disease (COPD) (4).”
BackgroundModulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Self-citationDekhuijzen, P. N., Aben, K. K., Dekker, I., Aarts, L. P., Wielders, P. L., van Herwaarden, C. L., & Bast, A. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.154.3.8810624 · Cited by 503
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2309 · Cited by 453 · cited 1×
“This compound is a member of the PGF 2 a family of isomers (F 2 -isoprostanes) (15) and was formerly known as 8iso PGF 2 a (16).”
BackgroundSelf-citationNowak, J., Murray, J. J., Oates, J. A., & FitzGerald, G. A. (1987) · Circulation · doi:10.1161/01.cir.76.1.6 · Cited by 382
Self-citationLocalization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344
Self-citationOXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME
Baldwin, S., Grum, C., Boxer, L., Simon, R., Ketai, L., & Devall, L. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91895-7 · Cited by 331
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella, F., Healy, D., Lawson, J. A., & FitzGerald, G. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5861 · Cited by 286
Self-citationDelanty, N., Reilly, M. P., Pratico, D., Lawson, J. A., McCarthy, J. F., Wood, A. E., Ohnishi, S. T., Fitzgerald, D. J., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.95.11.2492 · Cited by 267
Self-citationCylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
Self-citationSymptoms of chronic bronchitis and the risk of coronary disease
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02374-4 · Cited by 244
IPF 2α -I: An index of lipid peroxidation in humans
Praticò, D., Barry, O. P., Lawson, J. A., Adiyaman, M., Hwang, S.-W., Khanapure, S. P., Iuliano, L., Rokach, J., & FitzGerald, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3449 · Cited by 219
Self-citationOxygen radicals in lung pathology
Doelman, C. J. A., & Bast, A. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90015-b · Cited by 218
Generation of 8-Epiprostaglandin F by Human Monocytes
Praticó, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 187
Self-citationAspects to Consider When Detecting and Measuring Lipid Peroxidation
Gutteridge, J. M. C. (1986) · Free Radical Research Communications · doi:10.3109/10715768609083149 · Cited by 171
Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivo
Morrow, J. D., Minton, T. A., Badr, K. F., & Roberts, L. J. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90128-7 · Cited by 164
Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr, H. A., Weyrich, A. S., Saetzler, R. K., Jurek, A., Arfors, K. E., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119417 · Cited by 158
Proteases and oxidants in experimental pulmonary inflammatory injury.
Schraufstätter, I. U., Revak, S. D., & Cochrane, C. G. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111303 · Cited by 152
Nomenclature of Isoprostanes: A Proposal
Rokach, J., KHANAPURE, S. P., Hwang, S., Adiyaman, M., Lawson, J. A., & FitzGerald, G. A. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00184-6 · Cited by 144
Self-citationRahman, I., Skwarska, E., & MacNee, W. (1997) · Thorax · doi:10.1136/thx.52.6.565 · Cited by 142
8-Epi-PGF2 Alpha, a Novel Noncyclooxygenase-Derived Prostaglandin, Constricts Airways in Vitro
Kawiková, I., Barnes, P. J., Takahashi, T., Tadjkarimi, S., Yacoub, M. H., & Belvisi, M. G. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564103 · Cited by 133
Postma, D. S., Renkema, T. E. J., Noordhoek, J. A., Faber, H., SLUITER, H. J., & Kauffman, H. F. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.1.57 · Cited by 126
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ
Banerjee, M. R., Kang, K. H., Morrow, J. D., Roberts, L. J., & Newman, J. H. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.3.h660 · Cited by 125
Protein kinase A phosphorylation enhances sodium channel currents in Xenopus oocytes
Smith, R. D., & Goldin, A. L. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.3.c660 · Cited by 108
Enhanced Lipid Peroxidation in Hepatic Cirrhosis
Praticò, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., FitzGerald, G. A., & Violi, F. (1998) · Journal of Investigative Medicine · doi:10.1177/108155899804600209 · Cited by 97
Self-citationPinamonti, S., Muzzoli, M., Chicca, M. C., Papi, A. A., Ravenna, F., Fabbri, L. M., & Ciaccia, A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00030-5 · Cited by 73
Mohsenin, V. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.4.1456 · Cited by 57
Enzymatic regulation of the prostaglandin response in a human model of inflammation
McAdam, B. F., & FitzGerald, G. A. (1996) · Springer eBooks · doi:10.1007/978-94-011-5386-7_13 · Cited by 4
Self-citation
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430407 · Cited by 1,078
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
Roberts, L. J., & Morrow, J. D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00264-6 · Cited by 996
Metadata
- Authors
- PRATICÒ, D., BASILI, S., VIERI, M., CORDOVA, C., VIOLI, F., & FITZGERALD, G. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-12-01
- Volume
- 158
- Issue
- 6
- Pages
- 1709-1714
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2000498200
- Cited by
- 255
- References
- 36
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.